** Shares in France's Valneva VLS.PA rise around 12%, leading gains on France's SBF120 .SBF120 index, after the vaccine maker reported a 38% increase in H1 sales and confirmed its FY outlook
** The results "were solid showing continued product sales growth and improved gross margin," brokerage Van Lanschot Kempen says
** It confirms Valneva as a top pick and reiterates its "buy" rating saying the company's valuation is depressed and still provides an attractive risk-reward
** By 07:18 GMT shares are at a six-months high with trade volumes above their full-day moving average in the past 30 days
** Including Tuesday's rise, the stock has gained over 90% YTD, after its value was slashed in half in 2024
(Reporting by Alessandro Parodi)
((Alessandro.Parodi@thomsonreuters.com;))